Diabetic neuropathy
Conditions
Interventions
This is a two-arm, single-blind, randomized controlled clinical trial. Intervention group: The 75 participants in this group will receive foot care instructions according to the International Working
Sponsors
Faculdade de Enfermagem - Universidade Estadual de Campinas
Unidade Básica de Saúde Porto Seguro
Eligibility
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Age between 18-65 years; diagnosis of diabetic peripheral neuropathy; ability to walk independently without equipment or devices.
Exclusion criteria
Exclusion criteria: Amputation of any part of the foot; ankle-brachial index < 0.9.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| It is expected that pain and symptoms of diabetic peripheral neuropathy will improve through treatment with photobiomodulation, based on a decrease in the painDETEC scale score, which assesses pain. | — |
Secondary
| Measure | Time frame |
|---|---|
| It is expected that the perception of stress related to diabetes mellitus will improve through photobiomodulation treatment, based on a decrease in the score on the Diabetes Distress Scale, which assesses the stress caused by the disease. | — |
Countries
Brazil
Contacts
Public ContactPriscila Polinario
Faculdade de Enfermagem - Universidade Estadual de Campinas
Outcome results
None listed